Chinese pharma companies to produce version of Pfizer's vacc

Beijing, Mar 18 (Prensa Latina) Five Chinese pharma companies have signed an agreement with a UN-backed organization to produce a generic version of Pfizer's antiviral Nirmatrelvir, used to treat Covid-19 patients, local press reported on Friday.

Related Keywords

Fosun Pharma , Shanghai Desano Pharmaceuticals Co , Zhejiang Huahai Pharmaceutical Co , Zhejiang Jiuzhou Pharmaceutical Co , Global Times , Apeloa Pharmaceutical , Shanghai Desano Pharmaceuticals , Medicines Patent ,